SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006950
Filing Date
2021-05-12
Accepted
2021-05-12 16:58:37
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atre-20210331x10q.htm 10-Q 1545502
2 EX-10.1 atre-20210331ex1016262d9.htm EX-10.1 94165
3 EX-31.1 atre-20210331ex3113ea338.htm EX-31.1 12924
4 EX-31.2 atre-20210331ex312789b38.htm EX-31.2 12922
5 EX-32.1 atre-20210331ex3214d0d11.htm EX-32.1 8181
6 GRAPHIC atre-20210331ex1016262d9001.jpg GRAPHIC 6639
  Complete submission text file 0001558370-21-006950.txt   6075782

Data Files

Seq Description Document Type Size
7 EX-101.INS atre-20210331.xml EX-101.INS 1319995
8 EX-101.SCH atre-20210331.xsd EX-101.SCH 38875
9 EX-101.CAL atre-20210331_cal.xml EX-101.CAL 49534
10 EX-101.DEF atre-20210331_def.xml EX-101.DEF 158070
11 EX-101.LAB atre-20210331_lab.xml EX-101.LAB 332168
12 EX-101.PRE atre-20210331_pre.xml EX-101.PRE 287083
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 21915904
SIC: 2834 Pharmaceutical Preparations